AOD-9604 burns fat without the downsides of dieting or medication.
Simple answer
AOD-9604 fat-loss claims are ahead of the evidence. Animal and mechanism data do not prove reliable human body-composition results, and FDA/product-quality plus anti-doping caveats make it high-caution territory rather than a normal supplement shortcut.
What to do in practice
Do not treat the original claim as a rule. Use the simple answer first, then check the evidence trail below before changing training, nutrition, or supplement decisions.
Who this is for / not for
- Use this as claim evaluation, not medical advice, prescribing guidance, dosing guidance, or a product recommendation.
- Pregnancy, medication use, kidney disease, eating-disorder history, cardiac symptoms, medically supervised weight loss, abnormal labs, and real injuries belong with qualified clinician guidance.
- For peptides, drugs, injury-healing, hormone, and rapid fat-loss claims, the answer stays on proof, safety, legality, product quality, and anti-doping risk. No sourcing, injection, or protocol advice.
Deeper analysis
What scientific research says
AOD-9604 has animal and mechanism evidence around fat oxidation and lipid metabolism, but that does not establish a reliable human fat-loss shortcut. A safety/metabolism paper summarizes human trials as generally tolerated but not consistently effective, and FDA plus anti-doping sources keep safety, product-quality, regulatory, and sport-rule caveats central.
Interesting related points
- Check whether the evidence measures the exact outcome being claimed.
- Look for dose, population, and comparison details before turning the claim into a rule.
- Treat the source, study quality, and open review notes as context for how strongly to act on the claim.
What would change the answer
Stronger direct evidence, better source context, or a clearer dose, population, and outcome could shift the verdict. Until then, the claim should be treated as overstated.
Evidence trail
- FDA: Certain bulk drug substances for use in compounding that may present significant safety risksguideline
- Stier et al. Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health (2013)study
- Heffernan et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment (2001)study
- Heffernan et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice (2001)study
- Cox et al. Detection and in vitro metabolism of AOD9604 (2015)study
- WADA: 2026 Prohibited Listguideline
- USADA: World Anti-Doping Agency Prohibited Listguideline
- Hall et al. Energy balance and its components: implications for body weight regulation (2012)study
Source context
“AOD-9604 burns fat without the downsides of dieting or medication.”
“AOD-9604 burns fat and helps weight loss without the downsides of dieting or prescription medication.”
No Lies Lifting keeps the source context in an archived record so the claim can be checked without relying on a volatile creator URL.
Spot an issue or have a stronger source?
Propose a correction, missing nuance, or source for the editorial team to review. Reader proposals do not change the page automatically.